NuProbe, based in Houston, TX, is a genomics company specializing in developing high-sensitivity research assays for detecting and monitoring low-frequency mutations, gene fusions, and copy number variations. Their innovative technologies, including Blocker Displacement Amplification (BDA) and Quantitative Amplicon Sequencing (QASeq), enable the selective amplification and detection of rare DNA biomarkers with exceptional sensitivity.
With a focus on accelerating precision oncology worldwide, NuProbe offers custom assay development and testing services for clinical and research laboratories, as well as pharma companies. Their products allow for the detection and quantification of low-abundant variants from both cell-free DNA and tissue specimens, supporting biomarker detection programs at all stages.
Generated from the website